Zydus Hospira Oncology Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 15.00 Cr
as on 11-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.00 Cr
as on 11-07-2024
- Satisfied Charges ₹ 210.00 Cr
as on 11-07-2024
- Revenue -7.60%
(FY 2022)
- Profit -38.40%
(FY 2022)
- Ebitda -28.30%
(FY 2022)
- Net Worth -6.94%
(FY 2022)
- Total Assets -3.16%
(FY 2022)
About Zydus Hospira Oncology
The Corporate was formerly known as Zydus Mayne Oncology Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 15.00 Cr.
The company currently has active open charges totaling ₹40.00 Cr. The company has closed loans amounting to ₹210.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zydus Hospira Oncology Private Limited India is Umesh Singh as COMPANY SECRETARY. Ganesh Nayak, Nitinkumar Parekh, Prashant Sharma, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046246
- Company No.
046246
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zydus Hospira Oncology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Singh | Company Secretary | 14-Oct-2020 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Sharma  | Director | 18-Aug-2021 | Current |
| Nitinkumar Parekh | Director | 11-Feb-2014 | Current |
| Ganesh Nayak | Director | 24-Jan-2006 | Current |
Sonya Kakkar  | Director | 25-Jul-2022 | Current |
| Arvind Sharma | Whole-Time Director | 09-Oct-2020 | Current |
| Vikramkumar Shukla | Director | 04-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Zydus Hospira Oncology.
Zydus Hospira Oncology Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.6% decrease. The company also saw a substantial fall in profitability, with a 38.4% decrease in profit. The company's net worth dipped by a decrease of 6.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zydus Hospira Oncology?
In 2021, Zydus Hospira Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pfizer Healthcare India Private LimitedActive 15 years 1 monthVikramkumar Shukla and Andrew Chatfield are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Aug 2014 | ₹40.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 15 Dec 2014 | ₹25.00 Cr | Satisfied |
Standard Chartered Bank Creation Date: 23 Mar 2010 | ₹30.00 Cr | Satisfied |
How Many Employees Work at Zydus Hospira Oncology?
Zydus Hospira Oncology has a workforce of 435 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zydus Hospira Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Hospira Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
